Bepirovirsen is a novel antisense oligonucleotide with the potential to be used for chronic HBV infection, currently in clinical trials (NCT02981602). It acts by targeting all HBV messenger RNAs, leading to reductions in HBV-derived RNAs, HBV DNA and viral proteins.

纯度：≥98%

CAS：1403787-62-1